BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oki E, Tokunaga S, Emi Y, Kusumoto T, Yamamoto M, Fukuzawa K, Takahashi I, Ishigami S, Tsuji A, Higashi H, Nakamura T, Saeki H, Shirabe K, Kakeji Y, Sakai K, Baba H, Nishimaki T, Natsugoe S, Maehara Y; Kyushu Study Group of Clinical Cancer. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer 2016;19:968-76. [DOI: 10.1007/s10120-015-0530-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Nakamichi N, Tsujiura M, Matsui T, Yamamoto T, Yoshioka A, Hiramoto H, Ouchi Y, Ishimoto T, Kosuga T, Mochizuki S, Nakashima S, Bamba M, Masuyama M, Otsuji E. The therapeutic strategy for advanced gastric cancer with pyloric stenosis and liver metastasis; successfully treated by gastro-jejunal bypass and chemotherapy first, followed by curative R0 resection. Surg Case Rep 2021;7:6. [PMID: 33409765 DOI: 10.1186/s40792-020-00979-7] [Reference Citation Analysis]
2 Zhu YB, Zhao AG. Application of conversion therapy in advanced gastric cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(18): 2830-2837 [DOI: 10.11569/wcjd.v24.i18.2830] [Reference Citation Analysis]
3 Fujitani K, Kurokawa Y, Takeno A, Kawabata R, Omori T, Imamura H, Hirao M, Endo S, Kawada J, Moon JH, Kobayashi N, Takahashi T, Yamasaki M, Takiguchi S, Mori M, Eguchi H, Doki Y; Osaka University Clinical Research Group for Gastroenterological Surgery. Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate, and Operative Morbidity and Mortality. Ann Surg Oncol 2021. [PMID: 34480277 DOI: 10.1245/s10434-021-10750-3] [Reference Citation Analysis]
4 Nonaka Y, Hiramatsu K, Kato T, Shibata Y, Yoshihara M, Aoba T, Kamiya T. Evaluation of Hepatic Resection in Liver Metastasis of Gastric Cancer. Indian J Surg Oncol. 2019;10:204-209. [PMID: 30948900 DOI: 10.1007/s13193-018-0827-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Takeda FR, Garcia RN, Ueda SKN, Peixoto RD, Sallum RAA, Cecconello I. Primary tumor resection of metastatic gastric cancer in a multimodal era: Two case reports. Int J Surg Case Rep 2020;75:42-5. [PMID: 32919327 DOI: 10.1016/j.ijscr.2020.08.033] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Hori S, Honda M, Kobayashi H, Kawamura H, Takiguchi K, Muto A, Yamazaki S, Teranishi Y, Shiraso S, Kono K, Kamiga T, Iwao T, Yamashita N. A grading system for predicting the prognosis of gastric cancer with liver metastasis. Jpn J Clin Oncol 2021;51:1601-7. [PMID: 34491361 DOI: 10.1093/jjco/hyab140] [Reference Citation Analysis]
7 Zhou F, Yu XL, Liang P, Cheng Z, Han ZY, Yu J, Liu F, Hu Y. Microwave ablation is effective against liver metastases from gastric adenocarcinoma. Int J Hyperthermia 2017;33:830-5. [PMID: 28540787 DOI: 10.1080/02656736.2017.1306120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
8 Fukumitsu N, Okumura T, Takizawa D, Numajiri H, Ohnishi K, Mizumoto M, Aihara T, Ishikawa H, Tsuboi K, Sakurai H. Proton beam therapy for liver metastases from gastric cancer. J Radiat Res. 2017;58:357-362. [PMID: 27974509 DOI: 10.1093/jrr/rrw102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
9 Kroese TE, van Laarhoven HWM, Nilsson M, Lordick F, Guckenberger M, Ruurda JP, D'Ugo D, Haustermans K, van Cutsem E, van Hillegersberg R, van Rossum PSN. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis. Eur J Cancer 2022;166:254-69. [PMID: 35339868 DOI: 10.1016/j.ejca.2022.02.018] [Reference Citation Analysis]
10 Liao YY, Peng NF, Long D, Yu PC, Zhang S, Zhong JH, Li LQ. Hepatectomy for liver metastases from gastric cancer: a systematic review. BMC Surg. 2017;17:14. [PMID: 28193210 DOI: 10.1186/s12893-017-0215-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
11 Kanda M, Tanaka H, Shimizu D, Miwa T, Umeda S, Tanaka C, Kobayashi D, Hattori N, Suenaga M, Hayashi M, Iwata N, Yamada S, Fujiwara M, Kodera Y. SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells. Oncogene. 2018;37:5355-5366. [PMID: 29858600 DOI: 10.1038/s41388-018-0335-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
12 Omari J, Drewes R, Orthmer M, Hass P, Pech M, Powerski M. Treatment of metastatic gastric adenocarcinoma with image-guided high-dose rate, interstitial brachytherapy as second-line or salvage therapy. Diagn Interv Radiol 2019;25:360-7. [PMID: 31348004 DOI: 10.5152/dir.2019.18390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Sakaue M, Sugimura K, Masuzawa T, Takeno A, Katsuyama S, Shinnke G, Ikeshima R, Kawai K, Hiraki M, Katsura Y, Ohmura Y, Hata T, Takeda Y, Murata K. Long-term survival of HER2 positive gastric cancer patient with multiple liver metastases who obtained pathological complete response after systemic chemotherapy: A case report. Int J Surg Case Rep 2022;94:107097. [PMID: 35468379 DOI: 10.1016/j.ijscr.2022.107097] [Reference Citation Analysis]
14 Kinoshita J, Yamaguchi T, Moriyama H, Fushida S. Current status of conversion surgery for stage IV gastric cancer. Surg Today 2021. [PMID: 33486610 DOI: 10.1007/s00595-020-02222-0] [Reference Citation Analysis]
15 Tsunematsu M, Takahashi N, Murakami K, Misawa T, Akiba T, Yanaga K. Successful conversion surgery for gastric cancer with multiple liver metastases treated after S-1 plus cisplatin combination chemotherapy: a case report. Surg Case Rep 2017;3:95. [PMID: 28853036 DOI: 10.1186/s40792-017-0372-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, Wang C, Qiu MZ, Cai MY, Wu Q, Liu H, Guan WL, Zhou AP, Zhang YJ, Liu TS, Bi F, Yuan XL, Rao SX, Xin Y, Sheng WQ, Xu HM, Li GX, Ji JF, Zhou ZW, Liang H, Zhang YQ, Jin J, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-95. [PMID: 34197702 DOI: 10.1002/cac2.12193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Yazawa T, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Tani M, Sato A, Kamada Y, Tani R, Aoyama R, Sasaki Y, Zaima M. Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience. World J Gastrointest Pharmacol Ther 2020; 11(5): 110-122 [PMID: 33251035 DOI: 10.4292/wjgpt.v11.i5.110] [Reference Citation Analysis]
18 Takemura N, Saiura A. Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol 2017; 9(5): 242-251 [PMID: 28261381 DOI: 10.4254/wjh.v9.i5.242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
19 Kawaguchi Y, De Bellis M, Panettieri E, Duwe G, Vauthey JN. Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments. Surg Oncol Clin N Am 2021;30:205-18. [PMID: 33220806 DOI: 10.1016/j.soc.2020.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Beckert S, Königsrainer A. Oligometastasierung beim Magen- und Ösophaguskarzinom: Aktuelle Studienlage und chirurgische Konzepte. Chirurg 2018;89:505-9. [DOI: 10.1007/s00104-018-0645-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Kawahara K, Makino H, Kametaka H, Hoshino I, Fukada T, Seike K, Kawasaki Y, Otsuka M. Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis. World J Surg Oncol 2020;18:41. [PMID: 32093729 DOI: 10.1186/s12957-020-01816-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Schmidt T, Mönig SP. [Therapeutic approach in oligometastatic gastric and esophageal cancer]. Chirurg 2017;88:1024-32. [PMID: 29098307 DOI: 10.1007/s00104-017-0548-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
23 Ministrini S, Solaini L, Cipollari C, Sofia S, Marino E, D'Ignazio A, Bencivenga M, Tiberio GAM. Surgical treatment of hepatic metastases from gastric cancer. Updates Surg. 2018;70:273-278. [PMID: 29845462 DOI: 10.1007/s13304-018-0536-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
24 Guner A, Yildirim R. Surgical management of metastatic gastric cancer: moving beyond the guidelines. Transl Gastroenterol Hepatol 2019;4:58. [PMID: 31559339 DOI: 10.21037/tgh.2019.08.03] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
25 Wang J, Li Q, Cheng X, Zhang B, Lin J, Tang Y, Li F, Yang CS, Wang TC, Tu S. Bone Marrow-Derived Myofibroblasts Promote Gastric Cancer Metastasis by Activating TGF-β1 and IL-6/STAT3 Signalling Loop. Onco Targets Ther 2020;13:10567-80. [PMID: 33116635 DOI: 10.2147/OTT.S266506] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Kataoka K, Kinoshita T, Moehler M, Mauer M, Shitara K, Wagner AD, Schrauwen S, Yoshikawa T, Roviello F, Tokunaga M, Boku N, Ducreux M, Terashima M, Lordick F; EORTC GITCG Group and JCOG SCGC Group. Current management of liver metastases from gastric cancer: what is common practice? Gastric Cancer. 2017;20:904-912. [PMID: 28150070 DOI: 10.1007/s10120-017-0696-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
27 Sano K, Yamamoto M, Mimura T, Endo I, Nakamori S, Konishi M, Miyazaki M, Wakai T, Nagino M, Kubota K, Unno M, Sata N, Yamamoto J, Yamaue H, Takada T; Japanese Society of Hepato-Biliary-Pancreatic Surgery. Outcomes of 1,639 hepatectomies for non-colorectal non-neuroendocrine liver metastases: a multicenter analysis. J Hepatobiliary Pancreat Sci. 2018;25:465-475. [PMID: 30311741 DOI: 10.1002/jhbp.587] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
28 Xu H, Min X, Ren Y, Yang L, Liu F. Comparative Study of Drug-eluting Beads versus Conventional Transarterial Chemoembolization for Treating Peculiar Anatomical Sites of Gastric Cancer Liver Metastasis. Med Sci Monit 2020;26:e922988. [PMID: 32474569 DOI: 10.12659/MSM.922988] [Reference Citation Analysis]
29 Miwa T, Kanda M, Shimizu D, Umeda S, Sawaki K, Tanaka H, Tanaka C, Hattori N, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway. Br J Cancer 2021;124:1449-60. [PMID: 33531692 DOI: 10.1038/s41416-021-01271-7] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Luo Z, Rong Z, Huang C. Surgery Strategies for Gastric Cancer With Liver Metastasis. Front Oncol 2019;9:1353. [PMID: 31921626 DOI: 10.3389/fonc.2019.01353] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
31 Wang FH, Shen L, Li J, Zhou ZW, Liang H, Zhang XT, Tang L, Xin Y, Jin J, Zhang YJ, Yuan XL, Liu TS, Li GX, Wu Q, Xu HM, Ji JF, Li YF, Wang X, Yu S, Liu H, Guan WL, Xu RH. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun (Lond). 2019;39:10. [PMID: 30885279 DOI: 10.1186/s40880-019-0349-9] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 41.0] [Reference Citation Analysis]
32 Kitano T, Aisu Y, Yasukawa D, Hori T. Aggressive Graphic/Surgical R0 Resection and Jejunal Interposition with Preservation of Mesojejunal Autonomic Nerves in Patients with Stage IV Esophagogastric Junction Adenocarcinoma: A Report of 3 Cases. Am J Case Rep. 2019;20:465-473. [PMID: 30952831 DOI: 10.12659/ajcr.913960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
33 Gao F, Li M, Xiang R, Zhou X, Zhu L, Zhai Y. Expression of CLDN6 in tissues of gastric cancer patients: Association with clinical pathology and prognosis. Oncol Lett 2019;17:4621-5. [PMID: 30988820 DOI: 10.3892/ol.2019.10129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
34 Li Y, Wang P, Wu LL, Yan J, Pang XY, Liu SJ. miR-26a-5p Inhibit Gastric Cancer Cell Proliferation and Invasion Through Mediated Wnt5a. Onco Targets Ther 2020;13:2537-50. [PMID: 32273724 DOI: 10.2147/OTT.S241199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 Tatsubayashi T, Tanizawa Y, Miki Y, Tokunaga M, Bando E, Kawamura T, Sugiura T, Kinugasa Y, Uesaka K, Terashima M. Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer. 2017;20:387-393. [PMID: 27155874 DOI: 10.1007/s10120-016-0611-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
36 Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer 2016;19:329-38. [PMID: 26643880 DOI: 10.1007/s10120-015-0575-z] [Cited by in Crossref: 114] [Cited by in F6Publishing: 110] [Article Influence: 16.3] [Reference Citation Analysis]
37 Ito D, Kawaguchi Y, Yamashita H, Arita J, Akamatsu N, Kaneko J, Sakamoto Y, Kokudo N, Seto Y, Hasegawa K. Intestinal-type histology is associated with better prognosis in patients undergoing liver resection for gastric/esophagogastric-junction liver metastasis. Glob Health Med 2019;1:101-9. [PMID: 33330763 DOI: 10.35772/ghm.2019.01012] [Reference Citation Analysis]
38 Cui JK, Liu M, Shang XK. Hepatectomy for Liver Metastasis of Gastric Cancer: A Meta-Analysis. Surg Innov 2019;26:692-7. [PMID: 31267829 DOI: 10.1177/1553350619856491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Maehara Y, Soejima Y, Yoshizumi T, Kawahara N, Oki E, Saeki H, Akahoshi T, Ikegami T, Yamashita YI, Furuyama T, Sugimachi K, Harada N, Tagawa T, Harimoto N, Itoh S, Sonoda H, Ando K, Nakashima Y, Nagao Y, Yamashita N, Kasagi Y, Yukaya T, Kurihara T, Tsutsumi R, Takamori S, Sasaki S, Ikeda T, Yonemitsu Y, Fukuhara T, Kitao H, Iimori M, Kataoka Y, Wakasa T, Suzuki M, Teraishi K, Yoshida Y, Mori M. The evolution of surgical treatment for gastrointestinal cancers. Int J Clin Oncol 2019;24:1333-49. [PMID: 31522313 DOI: 10.1007/s10147-019-01499-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
40 Ding L, Zhang S, Chen S, Zheng L, Xiao L. Effect and mechanism of lentivirus-mediated silencing of TPX2 gene on proliferation and apoptosis of human hepatoma cells. J Cell Biochem 2018. [PMID: 30548299 DOI: 10.1002/jcb.28119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Nakajima TE, Sakamoto K, Hayano K, Mori Y, Asai K, Matsuyama R, Hirashita T, Hibi T, Sakai N, Tabata T, Kawakami H, Takeda H, Mizukami T, Ozaka M, Ueno M, Naito Y, Okano N, Ueno T, Hijioka S, Shikata S, Ukai T, Strasberg S, Sarr MG, Jagannath P, Hwang TL, Han HS, Yoon YS, Wang HJ, Luo SC, Adam R, Gimenez M, Scatton O, Oh DY, Takada T. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci 2021;28:1-25. [PMID: 33200538 DOI: 10.1002/jhbp.868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Shirasu H, Tsushima T, Kawahira M, Kawai S, Kawakami T, Kito Y, Yoshida Y, Hamauchi S, Todaka A, Yokota T, Machida N, Yamazaki K, Fukutomi A, Onozawa Y, Terashima M, Uesaka K, Yasui H. Role of hepatectomy in gastric cancer with multiple liver-limited metastases. Gastric Cancer. 2018;21:338-344. [PMID: 28577228 DOI: 10.1007/s10120-017-0730-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
43 Zhou B, He N, Hong J, Yang T, Ng DM, Gao X, Yan K, Fan X, Zheng Z, Chen P, Zheng J, Zheng Q. HIFU for the treatment of gastric cancer with liver metastases with unsuitable indications for hepatectomy and radiofrequency ablation: a prospective and propensity score-matched study. BMC Surg 2021;21:308. [PMID: 34253213 DOI: 10.1186/s12893-021-01307-y] [Reference Citation Analysis]
44 Marte G, Tufo A, Steccanella F, Marra E, Federico P, Petrillo A, Maida P. Efficacy of Surgery for the Treatment of Gastric Cancer Liver Metastases: A Systematic Review of the Literature and Meta-Analysis of Prognostic Factors. J Clin Med 2021;10:1141. [PMID: 33803135 DOI: 10.3390/jcm10051141] [Reference Citation Analysis]
45 Nitta H, Shimose T, Emi Y, Imamura T, Ohnishi K, Kusumoto T, Yamamoto M, Fukuzawa K, Takahashi I, Higashi H, Tsuji A, Akagi Y, Oki E, Maehara Y, Baba H; Kyushu Study Group of Clinical Cancer (KSCC) ancillary study. Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes. Med Oncol 2016;33. [DOI: 10.1007/s12032-016-0834-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
46 Watanabe H, Fujikawa H, Komori K, Kano K, Takahashi K, Yamada T, Inokuchi Y, Machida N, Yokose T, Rino Y, Masuda M, Ogata T, Oshima T. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy. Case Rep Gastroenterol 2021;15:562-7. [PMID: 34616257 DOI: 10.1159/000514396] [Reference Citation Analysis]
47 Fukami Y, Kaneoka Y, Maeda A, Takayama Y, Takahashi T, Uji M, Kumada T. Adjuvant hepatic artery infusion chemotherapy after hemihepatectomy for gastric cancer liver metastases. Int J Surg 2017;46:79-84. [PMID: 28882769 DOI: 10.1016/j.ijsu.2017.08.578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
48 Shi W, Wang J, Zhang W, Shou T. Long-term survival with stable disease after multidisciplinary treatment for synchronous liver metastases from gastric cancer: A case report. Int J Surg Case Rep 2019;65:317-21. [PMID: 31766011 DOI: 10.1016/j.ijscr.2019.08.021] [Reference Citation Analysis]
49 Salati M, Valeri N, Spallanzani A, Braconi C, Cascinu S. Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications. Eur J Surg Oncol 2019;45:1479-82. [PMID: 30448343 DOI: 10.1016/j.ejso.2018.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Zhang K, Chen L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases. Ther Adv Med Oncol. 2020;12:1758835920904803. [PMID: 32127925 DOI: 10.1177/1758835920904803] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
51 Takahashi Y, Seki H. Metastatic liver tumor from a primary gastric cancer with infiltration of the Glisson's pedicle: A case report. Int J Surg Case Rep 2019;60:38-41. [PMID: 31200213 DOI: 10.1016/j.ijscr.2019.05.012] [Reference Citation Analysis]
52 Zhang Z, Dou M, Yao X, Tang H, Li Z, Zhao X. Potential Biomarkers in Diagnosis of Human Gastric Cancer. Cancer Invest. 2016;34:115-122. [PMID: 26934336 DOI: 10.3109/07357907.2015.1114122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
53 Ikari N, Taniguchi K, Serizawa A, Yamada T, Yamamoto M, Furukawa T. A primary tumor of mixed histological type is a novel poor prognostic factor for patients undergoing resection of liver metastasis from gastric cancer. J Hepatobiliary Pancreat Sci. 2017;24:281-288. [PMID: 28273395 DOI: 10.1002/jhbp.445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Yu S, Hu C, Cai L, Du X, Lin F, Yu Q, Liu L, Zhang C, Liu X, Li W, Zhan Y. Seven-Gene Signature Based on Glycolysis Is Closely Related to the Prognosis and Tumor Immune Infiltration of Patients With Gastric Cancer. Front Oncol 2020;10:1778. [PMID: 33072557 DOI: 10.3389/fonc.2020.01778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
55 Wakabayashi T, Hibi T, Yoneda G, Iwao Y, Sawada Y, Hoshino H, Uemura S, Ban D, Kudo A, Takemura Y, Mishima K, Shinoda M, Itano O, Otsubo T, Endo I, Kitagawa Y, Tanabe M, Egawa H, Yamamoto M. Predictive model for survival after liver resection for noncolorectal liver metastases in the modern era: a Japanese multicenter analysis. J Hepatobiliary Pancreat Sci 2019;26:441-8. [PMID: 31271511 DOI: 10.1002/jhbp.654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Jagric T, Horvat M. Surgical resection of synchronous liver metastases in gastric cancer patients. A propensity score-matched study. Radiol Oncol 2020;55:57-65. [PMID: 33885239 DOI: 10.2478/raon-2020-0067] [Reference Citation Analysis]
57 Beeharry MK, Zhang TQ, Liu WT, Gang ZZ. Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research. World J Surg Oncol 2020;18:51. [PMID: 32151257 DOI: 10.1186/s12957-020-01819-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
58 Kodera Y. Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion? Ann Gastroenterol Surg 2018;2:339-47. [PMID: 30238074 DOI: 10.1002/ags3.12191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
59 Tanaka H, Kanda M, Shimizu D, Tanaka C, Kobayashi D, Hayashi M, Iwata N, Yamada S, Fujii T, Nakayama G. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer. Ann Surg Oncol. 2017;24:3438-3445. [PMID: 27770343 DOI: 10.1245/s10434-016-5636-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
60 Jung JO, Nienhüser H, Schleussner N, Schmidt T. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach. Int J Mol Sci 2020;21:E951. [PMID: 32023907 DOI: 10.3390/ijms21030951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
61 Song A, Zhang X, Yu F, Li D, Shao W, Zhou Y. Surgical resection for hepatic metastasis from gastric cancer: a multi- institution study. Oncotarget. 2017;8:71147-71153. [PMID: 29050350 DOI: 10.18632/oncotarget.16705] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
62 Yoshida K, Yasufuku I, Terashima M, Young Rha S, Moon Bae J, Li G, Katai H, Watanabe M, Seto Y, Hoon Noh S, Kwang Yang H, Ji J, Baba H, Kitagawa Y, Morita S, Nishiyama M, Kodera Y; CONVO‐GC‐1 Study Group, Federation of Asian Clinical Oncology (FACO). International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO‐GC‐1). Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12515] [Reference Citation Analysis]
63 Park JW, Jeong JM, Cho KS, Cho SY, Cheon JH, Choi DH, Park SJ, Kim HK. MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases. PLoS One 2021;16:e0250083. [PMID: 33852640 DOI: 10.1371/journal.pone.0250083] [Reference Citation Analysis]
64 Fukuda K, Arigami T, Tokuda K, Yanagita S, Matsushita D, Kawasaki Y, Iino S, Sasaki K, Nakajo A, Kirishima M, Tanimoto A, Tsubouchi H, Kurahara H, Ohtsuka T. Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report. surg case rep 2022;8. [DOI: 10.1186/s40792-022-01412-x] [Reference Citation Analysis]
65 Fonseca GM, Braghiroli MIFM, Pirola Kruger JA, Coelho FF, Herman P. Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies? Surg Oncol Clin N Am 2021;30:125-42. [PMID: 33220801 DOI: 10.1016/j.soc.2020.08.004] [Reference Citation Analysis]
66 Baba H, Kanda M, Sawaki K, Umeda S, Miwa T, Shimizu D, Tanaka C, Kobayashi D, Fujiwara M, Kodera Y, Fujii T. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer. Ann Surg Oncol 2020;27:2071-80. [DOI: 10.1245/s10434-019-07985-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Yang KS, Xu CQ, Lv J. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Bioengineered 2021;12:1238-50. [PMID: 33843442 DOI: 10.1080/21655979.2021.1911557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
68 Carmona-bayonas A, Jiménez-fonseca P, Echavarria I, Sánchez Cánovas M, Aguado G, Gallego J, Custodio A, Hernández R, Viudez A, Cano JM, Martínez de Castro E, Macías I, Martín Carnicero A, Garrido M, Mangas M, Álvarez Manceñido F, Visa L, Azkarate A, Ramchandani A, Fernández Montes A, Longo F, Sánchez A, Pimentel P, Limón ML, Arias D, Cacho Lavin D, Sánchez Bayona R, Cerdá P, García Alfonso P. Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry. European Journal of Surgical Oncology 2018;44:1191-8. [DOI: 10.1016/j.ejso.2018.03.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]